Literature DB >> 19932230

Health care utilization among surgically treated Medicare beneficiaries with lung cancer.

Farhood Farjah1, Douglas E Wood, Thomas K Varghese, Nader N Massarweh, Rebecca Gaston Symons, David R Flum.   

Abstract

BACKGROUND: Markers of increased health care utilization are surrogates for adverse events, and one such metric--prolonged length of stay greater than 14 days (PLOS)--was recently endorsed as a provider-level performance measure.
METHODS: This is a cohort study (1992 through 2002) aimed to describe increased health care utilization among 21,067 operated lung cancer patients using the Surveillance, Epidemiology, and End-Results-Medicare database. Increased utilization was defined by PLOS, discharge to an institutional care facility (ICF), or readmission within 30 days.
RESULTS: Twelve percent of patients had a PLOS, 13% were discharged to an ICF, and 15% were readmitted. In multivariate analyses, factors associated with a higher odds ratio of PLOS, discharge to ICF, or readmission included age older than 80 years, increasing comorbidity index, not being married, and pneumonectomy (all p < 0.05). Relative to patients living in the West, those in the Midwest or South had a higher odds ratio of PLOS and readmission but a lower odds ratio of discharge to an ICF (all p < 0.05). Adjusted rates of PLOS decreased significantly with time, whereas adjusted ICF and readmission rates increased (all p < 0.01). Patients who required increased utilization had higher adjusted 2.5-year mortality rates compared with those who did not (PLOS, 42% versus 20%; ICF, 32% versus 20%; readmission, 33% versus 19%; all p < 0.001).
CONCLUSIONS: Baseline health status and nonclinical factors were associated with increased utilization, nonuniform trends in utilization were observed with time, and increased utilization was associated with worse long-term outcomes. These findings have implications for quality-improvement initiatives that measure increased health care utilization as a surrogate for provider performance.

Entities:  

Mesh:

Year:  2009        PMID: 19932230     DOI: 10.1016/j.athoracsur.2009.08.006

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

Review 1.  What is quality, and can we define it in lung cancer?-the case for quality improvement.

Authors:  Farhood Farjah; Frank C Detterbeck
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Healthcare utilization in women after abdominal surgery for ovarian cancer.

Authors:  Ruth McCorkle; Sangchoon Jeon; Elizabeth Ercolano; Peter Schwartz
Journal:  Nurs Res       Date:  2011 Jan-Feb       Impact factor: 2.381

3.  Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.

Authors:  Daniel H Ahn; Nishi Mehta; Jeffrey T Yorio; Yang Xie; Jingsheng Yan; David E Gerber
Journal:  Clin Lung Cancer       Date:  2013-07-22       Impact factor: 4.785

4.  Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.

Authors:  Sunny Wang; Melisa L Wong; Nathan Hamilton; J Ben Davoren; Thierry M Jahan; Louise C Walter
Journal:  J Clin Oncol       Date:  2012-03-26       Impact factor: 44.544

5.  The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes.

Authors:  Felix G Fernandez; Andrzej S Kosinski; William Burfeind; Bernard Park; Malcolm M DeCamp; Christopher Seder; Blair Marshall; Mitchell J Magee; Cameron D Wright; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2016-05-19       Impact factor: 4.330

6.  Unexpected readmission after lung cancer surgery: A benign event?

Authors:  Varun Puri; Aalok P Patel; Traves D Crabtree; Jennifer M Bell; Stephen R Broderick; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan F Meyers
Journal:  J Thorac Cardiovasc Surg       Date:  2015-08-28       Impact factor: 5.209

7.  Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality.

Authors:  Yinin Hu; Timothy L McMurry; James M Isbell; George J Stukenborg; Benjamin D Kozower
Journal:  J Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 5.209

8.  A population-based study of hospital length of stay and emergency readmission following surgery for non-small-cell lung cancer.

Authors:  Joseph McDevitt; Maria Kelly; Harry Comber; Tracey Kelleher; Fiona Dwane; Linda Sharp
Journal:  Eur J Cardiothorac Surg       Date:  2013-07-25       Impact factor: 4.191

9.  Comorbidity is independently associated with poor outcome in extremity soft tissue sarcoma.

Authors:  Seungcheol Kang; Han-Soo Kim; Wanlim Kim; Jun Ho Kim; So Hyun Kang; Ilkyu Han
Journal:  Clin Orthop Surg       Date:  2015-02-10

10.  Hospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients.

Authors:  Robert M Van Haren; Arlene M Correa; Boris Sepesi; David C Rice; Wayne L Hofstetter; Jack A Roth; Stephen G Swisher; Garrett L Walsh; Ara A Vaporciyan; Reza J Mehran; Mara B Antonoff
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.